MedTrace Logo

NewBreez Safety and Efficacy Evaluation

NCT01587664 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-04-11

No results posted yet for this study

Summary

The objective of this clinical study is to evaluate the safety and efficacy of the NewBreez intra-laryngeal implant in patients with dysfunctional larynx.

Conditions

  • Swallowing Disorders

Interventions

DEVICE

NewBreez ILP

NewBreez ILP implantation

Sponsors & Collaborators

  • ProTiP Medical

    lead INDUSTRY

Principal Investigators

  • Marc Remacle, Prof. · UCL Mont-Godinne (Belgium)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587664 on ClinicalTrials.gov